Rule could make more medications available over the counter through a process called Additional Condition of Non-prescription Use (ACNU).
The biotherapeutics company said the treatment, LYT-200, is being evaluated in two ongoing clinical trials. It was previously granted orphan drug designation for the treatment of acute myeloid ...